Sage Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020
Period Ending	Aug '25 Aug 5, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2020
Market Capitalization	42,050	47,020	-	-	-	-	Upgrade
Enterprise Value	55,360	55,429	-	-	-	-	Upgrade
Last Close Price	589.80	662.60	-	-	-	-	Upgrade
PE Ratio	60.99	69.28	-	-	-	-	Upgrade
PS Ratio	3.48	3.89	-	-	-	-	Upgrade
PB Ratio	9.16	10.24	-	-	-	-	Upgrade
P/OCF Ratio	11.60	12.97	-	-	-	-	Upgrade
EV/Sales Ratio	4.58	4.59	-	-	-	-	Upgrade
EV/EBITDA Ratio	13.76	13.78	-	-	-	-	Upgrade
EV/EBIT Ratio	43.75	43.81	-	-	-	-	Upgrade
Debt / Equity Ratio	3.08	3.08	2.92	2.95	3.15	1.74	Upgrade
Debt / EBITDA Ratio	3.51	3.51	2.99	3.16	4.09	3.31	Upgrade
Asset Turnover	0.62	0.62	0.73	0.73	0.48	0.45	Upgrade
Inventory Turnover	2105.68	2105.68	737.17	234.13	131.34	61.16	Upgrade
Quick Ratio	0.36	0.36	0.27	0.22	0.28	1.03	Upgrade
Current Ratio	0.71	0.71	0.65	0.49	0.57	2.33	Upgrade
Return on Equity (ROE)	19.10%	19.10%	-8.35%	-35.32%	-46.57%	-40.81%	Upgrade
Return on Assets (ROA)	4.05%	4.05%	2.68%	0.73%	-2.97%	-1.21%	Upgrade
Return on Capital (ROIC)	5.54%	5.54%	3.77%	1.02%	-3.94%	-1.65%	Upgrade
Earnings Yield	1.61%	1.44%	-	-	-	-	Upgrade
Buyback Yield / Dilution	-11.29%	-11.29%	-9.72%	-90.76%	-	-0.31%	Upgrade

Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.